TY - JOUR
T1 - Diagnosis of brain diseases in fusion of neuroimaging modalities using deep learning
T2 - a review
AU - Shoeibi, Afshin
AU - Khodatars, Marjane
AU - Jafari, Mahboobeh
AU - Ghassemi, Navid
AU - Moridian, Parisa
AU - Alizadehsani, Roohallah
AU - Ling, Sai Ho
AU - Khosravi, Abbas
AU - Alinejad-Rokny, Hamid
AU - Lam, H. K.
AU - Fuller-Tyszkiewicz, Matthew
AU - Acharya, U. Rajendra
AU - Anderson, Donovan
AU - Zhang, Yudong
AU - Gorriz, Juan Manuel
PY - 2023/5
Y1 - 2023/5
N2 - Brain diseases, including tumors and mental and neurological disorders, seriously threaten the health and well-being of millions of people worldwide. Structural and functional neuroimaging modalities are commonly used by physicians to aid the diagnosis of brain diseases. In clinical settings, specialist doctors typically fuse the magnetic resonance imaging (MRI) data with other neuroimaging modalities for brain disease detection. As these two approaches offer complementary information, fusing these neuroimaging modalities helps physicians accurately diagnose brain diseases. Typically, fusion is performed between a functional and a structural neuroimaging modality. Because the functional modality can complement the structural modality information, thus improving the performance for the diagnosis of brain diseases by specialists. However, analyzing the fusion of neuroimaging modalities is difficult for specialist doctors. Deep Learning (DL) is a branch of artificial intelligence that has shown superior performances compared to more conventional methods in tasks such as brain disease detection from neuroimaging modalities. This work presents a comprehensive review paper in the field of brain disease detection from the fusion of neuroimaging modalities using DL models like convolutional neural networks (CNNs), recurrent neural networks (RNNs), pretrained, generative adversarial networks (GANs), and Autoencoders (AEs). First, neuroimaging modalities and the need for fusion are discussed. Then, review papers published in the field of neuroimaging multimodalities using AI techniques are explored. Moreover, fusion levels based on DL methods, including input, layer, and decision, with related studies conducted on diagnosing brain diseases, are discussed. Other sections present the most important challenges for diagnosing brain diseases from the fusion of neuroimaging modalities. In the discussion section, the details of previous research on the fusion of neuroimaging modalities based on MRI and DL models are reported. In the following, the most important future directions include Datasets, DA, imbalanced data, DL models, explainable AI, and hardware resources are presented. Finally, the main findings of this study are presented in the conclusion section.
AB - Brain diseases, including tumors and mental and neurological disorders, seriously threaten the health and well-being of millions of people worldwide. Structural and functional neuroimaging modalities are commonly used by physicians to aid the diagnosis of brain diseases. In clinical settings, specialist doctors typically fuse the magnetic resonance imaging (MRI) data with other neuroimaging modalities for brain disease detection. As these two approaches offer complementary information, fusing these neuroimaging modalities helps physicians accurately diagnose brain diseases. Typically, fusion is performed between a functional and a structural neuroimaging modality. Because the functional modality can complement the structural modality information, thus improving the performance for the diagnosis of brain diseases by specialists. However, analyzing the fusion of neuroimaging modalities is difficult for specialist doctors. Deep Learning (DL) is a branch of artificial intelligence that has shown superior performances compared to more conventional methods in tasks such as brain disease detection from neuroimaging modalities. This work presents a comprehensive review paper in the field of brain disease detection from the fusion of neuroimaging modalities using DL models like convolutional neural networks (CNNs), recurrent neural networks (RNNs), pretrained, generative adversarial networks (GANs), and Autoencoders (AEs). First, neuroimaging modalities and the need for fusion are discussed. Then, review papers published in the field of neuroimaging multimodalities using AI techniques are explored. Moreover, fusion levels based on DL methods, including input, layer, and decision, with related studies conducted on diagnosing brain diseases, are discussed. Other sections present the most important challenges for diagnosing brain diseases from the fusion of neuroimaging modalities. In the discussion section, the details of previous research on the fusion of neuroimaging modalities based on MRI and DL models are reported. In the following, the most important future directions include Datasets, DA, imbalanced data, DL models, explainable AI, and hardware resources are presented. Finally, the main findings of this study are presented in the conclusion section.
KW - Brain diseases
KW - MRI
KW - Neuroimaging
KW - Fusion
KW - Multimodality
KW - Deep learning
UR - http://www.scopus.com/inward/record.url?scp=85144620414&partnerID=8YFLogxK
U2 - 10.1016/j.inffus.2022.12.010
DO - 10.1016/j.inffus.2022.12.010
M3 - Short survey
AN - SCOPUS:85144620414
SN - 1566-2535
VL - 93
SP - 85
EP - 117
JO - Information Fusion
JF - Information Fusion
ER -